{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:18:27Z","timestamp":1761862707714},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1111\/j.1567-1364.2007.00321.x","type":"journal-article","created":{"date-parts":[[2007,11,8]],"date-time":"2007-11-08T21:44:32Z","timestamp":1194558272000},"page":"257-265","source":"Crossref","is-referenced-by-count":6,"title":["Synthesis of FUDP-<i>N<\/i>-acetylglucosamine and FUDP-glucose in<i>Saccharomyces cerevisiae<\/i>cells treated with 5-fluorouracil"],"prefix":"10.1093","volume":"8","author":[{"given":"Mar\u00c3\u00ada A.","family":"G\u00c3\u00bcnther Sillero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"P\u00c3\u00a9rez-Z\u00c3\u00ba\u00c3\u00b1iga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Silles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Sillero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB1","unstructured":"Berne M , Gustavsson B , Almersjo O , Spears P & Sundstrom E (1988) Inhibition of thymidylate synthase after administration of doxifluridine in a transplantable colon carcinoma in the rat. Cancer Invest 6: 377\u00e2\u0080\u0093383."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB2","doi-asserted-by":"crossref","unstructured":"Chen TB , Bajzer Z , Macura S & Vuk-Pavlovic S (1999) Differences in metabolism of 5-fluorouracil and 5-fluorouridine and regulation by glucosamine in human colon cancer multicell tumor spheroids. NMR Biomed 12: 157\u00e2\u0080\u0093167.","DOI":"10.1002\/(SICI)1099-1492(199905)12:3<157::AID-NBM551>3.0.CO;2-I"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB3","unstructured":"Cuezva JM , Krajewska M , de Heredia ML , Krajewski S , Santamaria G , Kim H , Zapata JM , Marusawa H , Chamorro M & Reed JC (2002) The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62: 6674\u00e2\u0080\u00936681."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB4","unstructured":"Dang CV & Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24: 68\u00e2\u0080\u009372."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB5","doi-asserted-by":"crossref","unstructured":"Douillard JY , Hoff PM , Skillings JR et al. (2002) Multicenter phase III study of uracil\/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3605\u00e2\u0080\u00933616.","DOI":"10.1200\/JCO.2002.04.123"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB7","unstructured":"Dreyer R & Cadman E (1981) Use of periodate and methylamine for the quantitation of intracellular 5-fluoro-2\u00e2\u0080\u00b2-deoxyuridine-5\u00e2\u0080\u00b2-monophosphate by high-performance liquid chromatography. J Chromatogr 219: 273\u00e2\u0080\u0093284."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB8","doi-asserted-by":"crossref","unstructured":"Fang F , Hoskins J & Butler JS (2004) 5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs. Mol Cell Biol 24: 10766\u00e2\u0080\u009310776.","DOI":"10.1128\/MCB.24.24.10766-10776.2004"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB9","unstructured":"Iigo M , Kuretani K & Hoshi A (1983) Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system. Cancer Res 43: 5687\u00e2\u0080\u00935694."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB10","doi-asserted-by":"crossref","unstructured":"Kato H , Ichinose Y , Ohta M , Hata E , Tsubota N , Tada H , Watanabe Y , Wada H , Tsuboi M & Hamajima N (2004) A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350: 1713\u00e2\u0080\u00931721.","DOI":"10.1056\/NEJMoa032792"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB11","first-page":"524","volume-title":"Methods of Enzymatic Analysis","author":"Keppler","year":"1985"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB12","doi-asserted-by":"crossref","unstructured":"Longley DB , Harkin DP & Johnston PG (2003) 5-fluorouracil mechanisms of action and clinical strategies. Nat Rev Cancer 3: 330\u00e2\u0080\u0093338.","DOI":"10.1038\/nrc1074"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB13","doi-asserted-by":"crossref","unstructured":"Lum PY , Armour CD , Stepaniants SB et al. (2004) Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116: 121\u00e2\u0080\u0093137.","DOI":"10.1016\/S0092-8674(03)01035-3"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB14","doi-asserted-by":"crossref","unstructured":"Malet-Martino M & Martino R (2002) Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. Oncologist 7: 288\u00e2\u0080\u0093323.","DOI":"10.1634\/theoncologist.7-4-288"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB15","doi-asserted-by":"crossref","unstructured":"Martino R , Gilard V , Desmoulin F & Malet-Martino M (2005) Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs. J Pharm Biomed Anal 38: 871\u00e2\u0080\u0093891.","DOI":"10.1016\/j.jpba.2005.01.047"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB16","doi-asserted-by":"crossref","unstructured":"Milewski S , Gabriel I & Olchowy J (2006) Enzymes of UDP-GlcNAc biosynthesis in yeast. Yeast 23: 1\u00e2\u0080\u009314.","DOI":"10.1002\/yea.1337"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB18","doi-asserted-by":"crossref","unstructured":"Osorio H , Carvalho E , del Valle M , G\u00c3\u00bcnther Sillero MA , Moradas-Ferreira P & Sillero A (2003) H2O2, but not menadione, provokes a decrease in the ATP and an increase in the inosine levels in Saccharomyces cerevisiae. An experimental and theoretical approach. Eur J Biochem 270: 1578\u00e2\u0080\u00931589.","DOI":"10.1046\/j.1432-1033.2003.03529.x"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB17","unstructured":"Osorio H , Moradas-Ferreira P , G\u00c3\u00bcnther Sillero MA & Sillero A (2004) In Saccharomyces cerevisiae, the effect of H2O2 on ATP, but not on glyceraldehyde-3-phosphate dehydrogenase, depends on the glucose concentration. Arch Microbiol 181: 231\u00e2\u0080\u0093236."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB19","unstructured":"Osorio H , Silles E , Maia R , Peleteiro B , Moradas-Ferreira P , G\u00c3\u00bcnther Sillero MA & Sillero A (2005) Influence of chronological aging on the survival and nucleotide content of Saccharomyces cerevisiae cells grown in different conditions: occurrence of a high concentration of UDP-N-acetylglucosamine in stationary cells grown in 2% glucose. FEMS Yeast Res 5: 387\u00e2\u0080\u0093398."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB20","doi-asserted-by":"crossref","unstructured":"Pederson NV , Zanghi JA , Miller WM & Knop RH (1994) Discrimination of fluorinated uridine metabolites in N-417 small cell lung cancer cell extracts via 19F- and 31P-NMR. Magn Reson Med 31: 224\u00e2\u0080\u0093228.","DOI":"10.1002\/mrm.1910310217"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB21","unstructured":"Peters GJ , Laurensse E , Lankelma J , Leyva A & Pinedo HM (1984) Separation of several 5-fluorouracil metabolites in various melanoma cell lines. Evidence for the synthesis of 5-fluorouracil-nucleotide sugars. Eur J Cancer Clin Oncol 20: 1425\u00e2\u0080\u00931431."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB22","unstructured":"Peterson MS , Ingraham HA & Goulian M (1983) 2\u00e2\u0080\u00b2-deoxyribosyl analogues of UDP-N-acetylglucosamine in cells treated with methotrexate or 5-fluorodeoxyuridine. J Biol Chem 258: 10831\u00e2\u0080\u009310834."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB23","unstructured":"Pinedo HM & Peters GF (1988) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6: 1653\u00e2\u0080\u00931664."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB24","doi-asserted-by":"crossref","unstructured":"Pogolotti AL, Jr , Nolan PA & Santi DV (1981) Methods for the complete analysis of 5-fluorouracil metabolites in cell extracts. Anal Biochem 117: 178\u00e2\u0080\u0093186.","DOI":"10.1016\/0003-2697(81)90708-9"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB25","doi-asserted-by":"crossref","unstructured":"Seiple L , Jaruga P , Dizdaroglu M & Stivers JT (2006) Linking uracil base excision repair and 5-fluorouracil toxicity in yeast. Nucleic Acids Res 34: 140\u00e2\u0080\u0093151.","DOI":"10.1093\/nar\/gkj430"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB26","unstructured":"Thomas BJ & Rothstein R (1989) Elevated recombination rates in transcriptionally active DNA. Cell 56: 619\u00e2\u0080\u0093630."},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB27","doi-asserted-by":"crossref","unstructured":"Twelves C , Wong A , Nowacki MP et al. (2005) Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352: 2696\u00e2\u0080\u00932704.","DOI":"10.1056\/NEJMoa043116"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB28","doi-asserted-by":"crossref","unstructured":"Weckbecker G & Keppler DO (1984) Substrate properties of 5-fluorouridine diphospho sugars detected in hepatoma cells. Biochem Pharmacol 33: 2291\u00e2\u0080\u00932298.","DOI":"10.1016\/0006-2952(84)90669-5"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB29","doi-asserted-by":"crossref","unstructured":"Yao L , Li Y , Wu Y , Liu A & Yan H (2005) Product release is rate-limiting in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase. Biochemistry 44: 5940\u00e2\u0080\u00935947.","DOI":"10.1021\/bi050095n"},{"key":"10.1111\/j.1567-1364.2007.00321.x-BIB30","unstructured":"Ziegler A , von Kienlin M , Decorps M & Remy C (2001) High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1\u00e2\u0080\u0083H magnetic resonance imaging. Cancer Res 61: 5595\u00e2\u0080\u00935600."}],"container-title":["FEMS Yeast Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsyr\/article-pdf\/8\/2\/257\/18018574\/8-2-257.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T22:54:35Z","timestamp":1708296875000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsyr\/article-lookup\/doi\/10.1111\/j.1567-1364.2007.00321.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1567-1364.2007.00321.x","relation":{},"ISSN":["1567-1356","1567-1364"],"issn-type":[{"value":"1567-1356","type":"print"},{"value":"1567-1364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}